Abstract
BackgroundSarilumab is a human mAb that blocks IL-6 from binding to both membrane-bound and soluble IL-6Rα (sIL-6R). A missense variant in the IL6R gene, Asp358Ala (rs2228145), falls within a proteolytic...
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have